HB 247 (2022): relative to treatment alternatives to opioids.
Cite this page
Granite Record indexes the General Court’s record; it is not that record. Where a citation allows only one source, cite the General Court — every page here links to what it is drawn from. The date below is the day the page was read.
- MLA
- “HB 247 (2022): relative to treatment alternatives to opioids.” Granite Record, https://graniterecord.org/bill/2022/hb247. Accessed 24 Oct. 2026.
- APA
- Granite Record. (n.d.). HB 247 (2022): relative to treatment alternatives to opioids. Retrieved 24 Oct. 2026, from https://graniterecord.org/bill/2022/hb247
- Chicago
- Granite Record. “HB 247 (2022): relative to treatment alternatives to opioids.” Accessed 24 Oct. 2026. https://graniterecord.org/bill/2022/hb247.
- BibTeX
@misc{bill-2022-hb247, title = {HB 247 (2022): relative to treatment alternatives to opioids.}, howpublished = {Granite Record}, url = {https://graniterecord.org/bill/2022/hb247}, note = {Accessed 24 Oct. 2026} }
HB 247 (2022)
relative to treatment alternatives to opioids.
- Status: Referred for interim study
- Term: 2021-2022
- House committee: Health, Human Services and Elderly Affairs
- Subject: Insurance
The Story
It was introduced on January 6, 2021 and referred to the House Health, Human Services and Elderly Affairs committee. The committee retained the bill, holding it for further work rather than reporting it out this year. The committee held a work session on October 6, 2021. The committee met in executive session on October 26, 2021 to vote on its recommendation. The committee voted unanimously, 21–0, to recommend that the House study it after the session ends, and the report was placed on the consent calendar. On January 5, 2022 the House voted to study it after the session ends on a voice vote. The committee held a work session on June 6, 2022. The committee reported back on its interim study of the bill: “Recommended for Future Legislation”, by a vote of 17 to 0.
Sponsors
- Rep. David Lundgren (R - Rock 5) (prime sponsor)
- Rep. Tom Dolan (R - Rock 5)
- Rep. Karel Crawford (R - Carr 4)
- Rep. Linda Massimilla (D - Graf 1)
- Rep. Richard Lascelles (R - Hills 20)
- Rep. David Love (R - Rock 6)
Hearings and Sessions
- January 26, 2021, 11:00 AM: public hearing, House Health, Human Services and Elderly Affairs
- October 6, 2021, 10:00 AM: subcommittee work session, House Health, Human Services and Elderly Affairs, LOB 205-207
- October 26, 2021, 9:30 AM: executive session, House Health, Human Services and Elderly Affairs, LOB 205-207
- June 6, 2022, 9:30 AM: work session, House Health, Human Services and Elderly Affairs, LOB 201-203
Votes
- January 5, 2022, House: Refer for Interim Study — voice vote, passed
The Docket
- January 6, 2021: Introduced (in recess of) 01/06/2021 and referred to Health, Human Services and Elderly Affairs
- January 26, 2021: Public Hearing: 01/26/2021 11:00 am Members of the public may attend using the following link: To join the webinar: https://www.zoom.us/j/94852322897 / Executive session on pending legislation may be held throughout the day (time permitting) from the time the committee is initially convened
- February 9, 2021: Retained in Committee
- October 6, 2021: Subcommittee Work Session: 10/06/2021 10:00 am LOB 205-207
- October 26, 2021: Executive Session: 10/26/2021 09:30 am LOB 205-207
- October 26, 2021: Committee Report: Refer for Interim Study HB247 10/26/2021 (Vote 21-0; CC)
- January 5, 2022: Refer for Interim Study: MA VV 01/05/2022
- June 6, 2022: Interim Study Work Session: 06/06/2022 09:30 am LOB 201-203
- October 19, 2022: Interim Study Report: Recommended for Future Legislation (Vote 17-0)
Laws It Would Change
Related Bills
- HB 554-FN (2024): relative to treatment alternatives to opioids.